Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Pediatric Blood & Cancer|June 21, 2018
Immunotherapy for osteosarcoma: Where do we go from here?Mary F Wedekind, Lars M Wagner, Timothy P CripeOncolytic Virotherapy|August 15, 2018
Oncolytic virus and PD-1/PD-L1 blockade combination therapyChun-Yu Chen, Brian Hutzen, Mary F Wedekind, et al.Journal of Pediatric Hematology/Oncology|March 19, 2016
The Effects of Hospital Length of Stay on Readmissions for Children With Newly Diagnosed Acute Lymphoblastic LeukemiaMary F Wedekind, Robyn Dennis, Mollie Sturm, et al.Pediatric Blood & Cancer|October 27, 2023
Childhood cancer data initiative: Status reportSubhashini Jagu, Elaine R Mardis, Mary F Wedekind, et al.Neuro-Oncology|April 8, 2023
Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patientsMyrsini Ioakeim-Ioannidou, Andrzej Niemierko, Daniel W Kim, et al.Journal for Immunotherapy of Cancer|July 1, 2026
ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinomaReona Okada, Arnulfo Mendoza, Darryl Nousome, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A Ligon, R Taylor Sundby, Mary F Wedekind, et al.JAMA Oncology|July 9, 2026
Global Consensus on the Management of Primary Localized ChordomaStefano Radaelli, Anna M Frezza, Piero Fossati, et al.Pageof 1